124 related articles for article (PubMed ID: 3509759)
1. [Inhibition of natural killer and interleukin 2-activated natural killer cell cytotoxicity by monosaccharides and lectins].
Imir T; Bankhurst AD
Mikrobiyol Bul; 1987 Oct; 21(4):245-50. PubMed ID: 3509759
[TBL] [Abstract][Full Text] [Related]
2. Effector cell sensitivity to sugar moieties. III. Inhibition by monosaccharides of interleukin-2 enhanced natural killing against viral and nonviral tumor target cells.
Ades EW; Hinson A; Culwell M
J Clin Lab Immunol; 1986 Feb; 19(2):65-9. PubMed ID: 3485719
[TBL] [Abstract][Full Text] [Related]
3. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
4. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
[TBL] [Abstract][Full Text] [Related]
5. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors suppress natural killer cell cytolytic activity.
Ogbomo H; Michaelis M; Kreuter J; Doerr HW; Cinatl J
FEBS Lett; 2007 Apr; 581(7):1317-22. PubMed ID: 17349632
[TBL] [Abstract][Full Text] [Related]
7. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
Dadmarz R; Bockstoce DC; Golub SH
Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
[TBL] [Abstract][Full Text] [Related]
9. Cellular immune response in rnu/rnu rats. I. Lectin responsiveness and IL-2 production kinetics of natural cytotoxicity and spleen-cell surface marker expression.
Sfaksi A; Bonneville M; Soulillou JP
Immunology; 1985 Aug; 55(4):655-62. PubMed ID: 3874820
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules.
Kubota A; Lian RH; Lohwasser S; Salcedo M; Takei F
J Immunol; 1999 Dec; 163(12):6488-93. PubMed ID: 10586040
[TBL] [Abstract][Full Text] [Related]
12. Effector cell sensitivity to sugar moieties. II. Inhibition by monosaccharides of interferon enhanced human natural killing.
Ades EW; Hinson A
J Clin Lab Immunol; 1983 Aug; 11(4):173-6. PubMed ID: 6199501
[TBL] [Abstract][Full Text] [Related]
13. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
Zollner TM; Zhu HG; Anderer FA
Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
[TBL] [Abstract][Full Text] [Related]
14. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
15. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
16. Thrombin modulation of natural killer activity in human peripheral lymphocytes.
Naldini A; Carney DH
Cell Immunol; 1996 Aug; 172(1):35-42. PubMed ID: 8806804
[TBL] [Abstract][Full Text] [Related]
17. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
18. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
19. Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
Hogan PG; Hapel AJ; Doe WF
J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882
[TBL] [Abstract][Full Text] [Related]
20. The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.
Kogure T; Mantani N; Goto H; Shimada Y; Tamura J; Terasawa K
Mediators Inflamm; 2002 Aug; 11(4):219-24. PubMed ID: 12396473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]